New Way to Treat Brain Diseases at Home Using Noninvasive Brain Stimulation
Date: November 5, 2020
Time: 08:30PM - 09:30PM
You must be registered to participate!
[Recorded Nov. 5, 2020]
The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care.
Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. In May, 2020, Neuroelectrics received FDA approval for a clinical trial of at-home brain stimulation therapy via telemedicine for patients with Major Depressive Disorder (MDD). An additional trial with Boston Children’s Hospital (IDE G160208) is already underway, studying the therapy for treatment-resistant epilepsy.
This nonaccredited educational webinar is provided for information only.
- Ana Maiques, MBA, CEO & Co-Founder, Neuroelectrics
- Dr. Eric J. Grigsby, MD, MBA, Founder & CEO, Neurovations: A Patient Care and Innovation Company
[Recorded Nov. 5, 2020]
The COVID-19 pandemic has highlighted a needs for non-invasive, remote approaches to patient care.
Learn how companies like Neuroelectrics are working to bring non-invasive brain stimulation into the home. In May, 2020, Neuroelectrics received FDA approval for a clinical trial of at-home brain stimulation therapy via telemedicine for patients with Major Depressive Disorder (MDD). An additional trial with Boston Children’s Hospital (IDE G160208) is already underway, studying the therapy for treatment-resistant epilepsy.
This nonaccredited educational webinar is provided for information only.